Structure-based view of epidermal growth factor receptor regulation

被引:270
作者
Ferguson, Kathryn M. [1 ]
机构
[1] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
关键词
EGFR; ligand-induced receptor dimerization; mechanisms of activation and inhibition; receptor tyrosine kinase;
D O I
10.1146/annurev.biophys.37.032807.125829
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
High-resolution X-ray crystal structures determined in the past six years dramatically influence our view of ligand-induced activation of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. Ligand binding to the extracellular region of EGFR promotesa major domain reorganization, plus local conformational changes, that are required to generate an entirely receptor-mediated dimer. In this activated complex the intracellular kinase domains associate to form on asymmetric dimer that supports the allosteric activation of one kinase. These models are discussed with emphasis on recent studies that add details or bolster the generality of this view of activation of this family of receptors. The EGFR family is implicated in several disease states, perhaps most notably in cancers. Activating tumor mutations have been identified in the intracellular and extracellular regions of EGFR. The impact of these tumor mutations on the understanding of EGFR activation and of its inhibition is discussed.
引用
收藏
页码:353 / 373
页数:21
相关论文
共 73 条
[1]   Structure and function of the type 1 insulin-like growth factor receptor [J].
Adams, TE ;
Epa, VC ;
Garrett, TPJ ;
Ward, CW .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) :1050-1093
[2]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[3]   HIGH-AFFINITY EPIDERMAL GROWTH-FACTOR BINDING IS SPECIFICALLY REDUCED BY A MONOCLONAL-ANTIBODY, AND APPEARS NECESSARY FOR EARLY RESPONSES [J].
BELLOT, F ;
MOOLENAAR, W ;
KRIS, R ;
MIRAKHUR, B ;
VERLAAN, I ;
ULLRICH, A ;
SCHLESSINGER, J ;
FELDER, S .
JOURNAL OF CELL BIOLOGY, 1990, 110 (02) :491-502
[4]   Disabling receptor ensembles with rationally designed interface peptidomimetics [J].
Berezov, A ;
Chen, JQ ;
Liu, QD ;
Zhang, HT ;
Greene, MI ;
Murali, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) :28330-28339
[5]  
Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107
[6]   The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand [J].
Bouyain, S ;
Longo, PA ;
Li, SQ ;
Ferguson, KM ;
Leahy, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) :15024-15029
[7]   TheEGF receptor family: spearheading a merger of signaling and therapeutics [J].
Bublil, Erez M. ;
Yarden, Yosef .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :124-134
[8]   An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors [J].
Burgess, AW ;
Cho, HS ;
Eigenbrot, C ;
Ferguson, KM ;
Garrett, TPJ ;
Leahy, DJ ;
Lemmon, MA ;
Sliwkowski, MX ;
Ward, CW ;
Yokoyama, S .
MOLECULAR CELL, 2003, 12 (03) :541-552
[9]  
CADENA DL, 1994, J BIOL CHEM, V269, P260
[10]  
CARPENTER CD, 1991, J BIOL CHEM, V266, P5750